Onkologie. 2009:3(1):44-47

Management of oropharyngeal mucositis pain and the role of transdermal opioids

MUDr. Samuel Vokurka
Hematologicko-onkologické oddělení, FN Plzeň

Oropharyngeal mucositis after high-dose chemotherapy or head and neck radiotherapy is accompanied with significant dyscomfort

and pains. Treatment and nursing options include local mouthwashes with bland solutions or viscous gels with or without topical anesthetics.

In more serious OM, tramadol and morphine are treatments of choice, with transdermal fentanyl as a possible alternative. Pain

management is one of basic components of global OM care. It must be individually targeted and stepwise escalated.

Keywords: mucositis, pain, opioids, fentanyl.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vokurka S. Management of oropharyngeal mucositis pain and the role of transdermal opioids. Onkologie. 2009;3(1):44-47.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Barasch A, Elad S, Altman A, Damato K, Epstein J. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 2006; 14: 528-532. Go to original source... Go to PubMed...
    2. Barber C, Powell R, Ellis A, Hewett J. Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Support Care Cancer 2007; 15: 427-440. Go to original source... Go to PubMed...
    3. Bellm LA, Epstein JB, Rose-Ped A et al. Patients reports of complications of bone marrow transplantation. Support Care Cancer 2000; 8: 33-39. Go to original source... Go to PubMed...
    4. Bensinger W, Schubert M, Ang KK et al. NCCN Task Force Report. prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 2008; 6 Suppl 1: 1-21. Go to original source...
    5. Blijlevens N, Schwenkglenks M, Bacon P et al. Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy. J Clin Oncol 2008; 26: 1519-1525. Go to original source... Go to PubMed...
    6. Cai Q, Huang H, Sun X et al. Eficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy. Expert Opin Pharmacother 2008; 9: 3137-3144. Go to original source... Go to PubMed...
    7. Demarosi F, Lodi G, Soligo D et al. Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone Marrow Transplant 2004; 33: 1247-1251. Go to original source... Go to PubMed...
    8. Epstein JB, Epstein JD, Epstein MS, Oien H, Truelove EL. Oral Doxepin Rinse: The Analgesic Effect and Duration of Pain Reduction in Patients with Oral Mucositis Due to Cancer Therapy. Anesth. Analg 2006; 103: 465-470. Go to original source... Go to PubMed...
    9. Flook C. Calman F, Mant M. Gelclair vs benzydamine in randomise controlled study in patients with oral mucositis due to readical radiotherapy. Supportive Care in Cancer 2005; 13: 443-444, abstr.15-098.
    10. Innocenti M, Moscatelli G, Lopez S. Efficacy of gelclair in reducing pain in palliative care patients with oral lesions: preliminary findings form an open pilot study. J Pain and Symptom Management 2002; 24: 456-457. Go to original source... Go to PubMed...
    11. Kim JG, Sohn SK, Kim DH et al. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. Transplant Proc 2005; 37: 4488-4491. Go to original source... Go to PubMed...
    12. Lever SA, Dupuis LL, Chan HS. Comparative evaluation of benzydamine oral rinse in childern with antineoplastic -induced stomatitis. Drug Intell Clin Pharm 1987; 21: 369-361. Go to original source... Go to PubMed...
    13. Niscola P, Romani C, Cupelli L et al. Mucositis in patients with hematologic malignancies: an overview. Haematologica 2007; 92: 222-231. Go to original source... Go to PubMed...
    14. Prada A, Chiesa F. Effects of benzydamine on the oral mucositis during antineoplastic radiotherypy and/or intra-arterial chemotherapy. Int J Tissue React 1987; 9: 115-119. Go to PubMed...
    15. Rubenstein EB, Peterson DE, Schubert M et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100 Suppl: 2026-2046. Go to original source... Go to PubMed...
    16. Strupp C, Sudhoff T, Germing U et al. Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support. Oncol Rep 2000; 7: 659-661. Go to original source... Go to PubMed...
    17. Škardová J, Kabátová-Maxová K, Vokurka S. Nové možnosti ošetřování mukozitidy dutiny ústní u pacientů po transplantaci krvetvorných buněk. Vnitřní lékařství 2008; 54 Suppl: 91.
    18. Vokurka S, Bystricka E, Koza V et al. The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT-results of a randomized multicentre study. Support Care Cancer 2005; 13: 554-558. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.